Unilabs to Develop Companion Dx for Biogen Idec Drug

Unilabs will develop a two-step ELISA test to detect anti-JCV antibodies to help stratify patients receiving Biogen Idec's Tysabri (natalizumab).

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories